Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
72.98
+0.93 (1.29%)
At close: Apr 3, 2025, 4:00 PM
72.25
-0.73 (-1.00%)
Pre-market: Apr 4, 2025, 4:31 AM EDT
Edwards Lifesciences Market Cap
Edwards Lifesciences has a market cap or net worth of $42.90 billion as of April 3, 2025. Its market cap has decreased by -24.30% in one year.
Market Cap
42.90B
Enterprise Value
39.62B
1-Year Change
-24.30%
Ranking
Category
Stock Price
$72.98
Market Cap Chart
Since March 27, 2000, Edwards Lifesciences's market cap has increased from $958.50M to $42.90B, an increase of 4,376.26%. That is a compound annual growth rate of 16.40%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 3, 2025 | 42.90B | -1.74% |
Dec 31, 2024 | 43.66B | -5.51% |
Dec 29, 2023 | 46.21B | 0.17% |
Dec 30, 2022 | 46.13B | -42.97% |
Dec 31, 2021 | 80.88B | 42.25% |
Dec 31, 2020 | 56.86B | 16.86% |
Dec 31, 2019 | 48.66B | 51.96% |
Dec 31, 2018 | 32.02B | 34.25% |
Dec 29, 2017 | 23.85B | 19.05% |
Dec 30, 2016 | 20.03B | 17.59% |
Dec 31, 2015 | 17.04B | 25.03% |
Dec 31, 2014 | 13.63B | 89.40% |
Dec 31, 2013 | 7.19B | -30.86% |
Dec 31, 2012 | 10.41B | 29.03% |
Dec 30, 2011 | 8.06B | -12.62% |
Dec 31, 2010 | 9.23B | 87.85% |
Dec 31, 2009 | 4.91B | 60.64% |
Dec 31, 2008 | 3.06B | 17.27% |
Dec 31, 2007 | 2.61B | -4.23% |
Dec 29, 2006 | 2.72B | 10.05% |
Dec 30, 2005 | 2.47B | 0.91% |
Dec 31, 2004 | 2.45B | 37.56% |
Dec 31, 2003 | 1.78B | 16.52% |
Dec 31, 2002 | 1.53B | -6.49% |
Dec 31, 2001 | 1.64B | 57.15% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 723.09B |
UnitedHealth Group | 478.50B |
Johnson & Johnson | 369.31B |
AbbVie | 364.89B |
Novo Nordisk | 307.98B |
Abbott Laboratories | 228.39B |
AstraZeneca | 227.81B |
Merck & Co. | 220.07B |